83 related articles for article (PubMed ID: 2474559)
21. Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.
Rothman SW; Brown JE; Diecidue A; Foret DA
Infect Immun; 1984 Nov; 46(2):324-31. PubMed ID: 6500693
[TBL] [Abstract][Full Text] [Related]
22. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin.
Krivan HC; Wilkins TD
Infect Immun; 1987 Aug; 55(8):1873-7. PubMed ID: 3112015
[TBL] [Abstract][Full Text] [Related]
23. Production, purification and characterization of Clostridium difficile toxic proteins different from toxin A and from toxin B.
Torres JF; Lönnroth I
Biochim Biophys Acta; 1989 Oct; 998(2):151-7. PubMed ID: 2506935
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the physicochemical interactions between Clostridium difficile toxins and cholestyramine using liquid chromatography with post-column derivatization.
Palace GP; Lazari P; Norton K
Biochim Biophys Acta; 2001 Mar; 1546(1):171-84. PubMed ID: 11257520
[TBL] [Abstract][Full Text] [Related]
25. Beta-endorphin-related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides, including the formerly unrecognized peptide beta-endorphin 1-18.
Vuolteenaho O
Acta Physiol Scand Suppl; 1984; 531():1-84. PubMed ID: 6091413
[TBL] [Abstract][Full Text] [Related]
26. Purification of RNA-core induced streptolysin S, and isolation and haemolytic characteristics of the carrier-free toxin.
Loridan C; Alouf JE
J Gen Microbiol; 1986 Feb; 132(2):307-15. PubMed ID: 3519856
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding.
Rolfe RD; Song W
J Med Microbiol; 1995 Jan; 42(1):10-9. PubMed ID: 7739018
[TBL] [Abstract][Full Text] [Related]
28. Partial purification of an osteolytic toxin from Pasteurella multocida.
Chanter N; Rutter JM; Mackenzie A
J Gen Microbiol; 1986 Apr; 132(4):1089-97. PubMed ID: 3760819
[TBL] [Abstract][Full Text] [Related]
29. Molecular screening of Clostridium difficile toxins A and B genetic determinants and identification of mutant strains.
McMillin DE; Muldrow LL; Leggette SJ; Abdulahi Y; Ekanemesang UM
FEMS Microbiol Lett; 1991 Feb; 62(1):75-80. PubMed ID: 1903351
[TBL] [Abstract][Full Text] [Related]
30. Purification of the insecticidal toxin in crystals of Bacillus thuringiensis.
Lilley M; Ruffell RN; Somerville HJ
J Gen Microbiol; 1980 May; 118(1):1-11. PubMed ID: 7420053
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus.
Bailey CJ; de Azavedo J; Arbuthnott JP
Biochim Biophys Acta; 1980 Jul; 624(1):111-20. PubMed ID: 6773585
[TBL] [Abstract][Full Text] [Related]
32. [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].
Gerlach D; Knöll H; Köhler W
Zentralbl Bakteriol A; 1980; 247(2):177-91. PubMed ID: 6775448
[TBL] [Abstract][Full Text] [Related]
33. Hyperphosphorylation of calnexin, a chaperone protein, induced by Clostridium difficile cytotoxin.
Schué V; Green GA; Girardot R; Monteil H
Biochem Biophys Res Commun; 1994 Aug; 203(1):22-8. PubMed ID: 8074658
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of the active fragment from Bacillus thuringiensis delta-toxin.
Tyski S; Fujii Y; Lai CY
Biochem Biophys Res Commun; 1986 Nov; 141(1):106-11. PubMed ID: 3026371
[TBL] [Abstract][Full Text] [Related]
35. Identification of a CHO cell-elongating factor produced by Vibrio cholerae O1.
McCardell BA; Kothary MH; Hall RH; Sathyamoorthy V
Microb Pathog; 2000 Jul; 29(1):1-8. PubMed ID: 10873485
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of Clostridium difficile strains by polymerase chain reaction with toxin A- and B-specific primers.
Wren BW; Heard SR; al-Saleh AI; Tabaqchali S
J Med Microbiol; 1993 Feb; 38(2):109-13. PubMed ID: 8429535
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of alpha-toxin produced by Clostridium novyi type A.
Ball DW; Van Tassell RL; Roberts MD; Hahn PE; Lyerly DM; Wilkins TD
Infect Immun; 1993 Jul; 61(7):2912-8. PubMed ID: 8514395
[TBL] [Abstract][Full Text] [Related]
38. Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion.
Govind R; Fitzwater L; Nichols R
J Bacteriol; 2015 Aug; 197(15):2600-9. PubMed ID: 26013487
[TBL] [Abstract][Full Text] [Related]
39. Quantitative cell-adhesion assay for Clostridium difficile cytotoxin.
Mayall BC; Edmonds C; Griffin GE
J Med Microbiol; 1987 Nov; 24(3):197-203. PubMed ID: 3669053
[TBL] [Abstract][Full Text] [Related]
40. Snake venom toxins. The amino-acid sequences of three toxins (CM-8, CM-11 and CM-13a) from Naja haje annulifera (Egyptian cobra) venom.
Joubert FJ
Eur J Biochem; 1976 Apr; 64(1):219-32. PubMed ID: 1278155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
